783 related articles for article (PubMed ID: 23891555)
1. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
[TBL] [Abstract][Full Text] [Related]
2. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
Takahashi K; Wall SB; Suzuki H; Smith AD; Hall S; Poulsen K; Kilian M; Mobley JA; Julian BA; Mestecky J; Novak J; Renfrow MB
Mol Cell Proteomics; 2010 Nov; 9(11):2545-57. PubMed ID: 20823119
[TBL] [Abstract][Full Text] [Related]
3. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
Renfrow MB; Cooper HJ; Tomana M; Kulhavy R; Hiki Y; Toma K; Emmett MR; Mestecky J; Marshall AG; Novak J
J Biol Chem; 2005 May; 280(19):19136-45. PubMed ID: 15728186
[TBL] [Abstract][Full Text] [Related]
4. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
[TBL] [Abstract][Full Text] [Related]
5. O-glycoforms of polymeric immunoglobulin A1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes.
Yu G; Zhang Y; Meng B; Xie X; Wang Z; Ying W; Lv J; Zhang H
Nephrol Dial Transplant; 2021 Dec; 37(1):33-41. PubMed ID: 34152412
[TBL] [Abstract][Full Text] [Related]
6. Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
Ohyama Y; Yamaguchi H; Nakajima K; Mizuno T; Fukamachi Y; Yokoi Y; Tsuboi N; Inaguma D; Hasegawa M; Renfrow MB; Novak J; Yuzawa Y; Takahashi K
Sci Rep; 2020 Jan; 10(1):671. PubMed ID: 31959827
[TBL] [Abstract][Full Text] [Related]
7. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Hiki Y; Tanaka A; Kokubo T; Iwase H; Nishikido J; Hotta K; Kobayashi Y
J Am Soc Nephrol; 1998 Apr; 9(4):577-82. PubMed ID: 9555659
[TBL] [Abstract][Full Text] [Related]
8.
Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of O-glycosylation in the hinge region of human IgA1.
Novak J; Tomana M; Kilian M; Coward L; Kulhavy R; Barnes S; Mestecky J
Mol Immunol; 2000 Dec; 37(17):1047-56. PubMed ID: 11399322
[TBL] [Abstract][Full Text] [Related]
10. Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy.
Renfrow MB; Mackay CL; Chalmers MJ; Julian BA; Mestecky J; Kilian M; Poulsen K; Emmett MR; Marshall AG; Novak J
Anal Bioanal Chem; 2007 Nov; 389(5):1397-407. PubMed ID: 17712550
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Potential of Plasma IgA1 O-Glycans in Discriminating IgA Nephropathy From Other Glomerular Diseases and Healthy Participants.
Zhang S; Sun H; Zhang Z; Li M; Guo Z; Ye W; Cai G; Sun W; Li M
Front Mol Biosci; 2022; 9():871615. PubMed ID: 35445079
[No Abstract] [Full Text] [Related]
12. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
[TBL] [Abstract][Full Text] [Related]
13. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide.
Iwase H; Tanaka A; Hiki Y; Kokubo T; Ishii-Karakasa I; Kobayashi Y; Hotta K
J Biochem; 1996 Aug; 120(2):393-7. PubMed ID: 8889826
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
17. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring structural isomers in serum IgA1 o-glycosylation.
Takahashi K; Smith AD; Poulsen K; Kilian M; Julian BA; Mestecky J; Novak J; Renfrow MB
J Proteome Res; 2012 Feb; 11(2):692-702. PubMed ID: 22067045
[TBL] [Abstract][Full Text] [Related]
19. Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry.
Tarelli E; Smith AC; Hendry BM; Challacombe SJ; Pouria S
Carbohydr Res; 2004 Sep; 339(13):2329-35. PubMed ID: 15337464
[TBL] [Abstract][Full Text] [Related]
20. Development of an enrichment-free one-pot sample preparation and ultra-high performance liquid chromatography-tandem mass spectrometry method to identify Immunoglobulin A1 hinge region O-glycoforms for Immunoglobulin A nephropathy.
Chen HF; Kao CC; Ka SM; Wang SY; Chen MX; Chen GY; Weng TI; Lai RY; Yeh SC; Lin YC; Chen HH; Chang WC; Wu MS; Tsai IL
J Chromatogr A; 2022 Dec; 1685():463589. PubMed ID: 36351322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]